All Articles

A new study finds 71% of data transformations pivot mid-project. This exposes the fatal flaw in rigid planning and makes the case for adaptive strategies.

ChipMOS Technologies' May revenue surged 17.7% year-over-year, fueled by AI chip demand. Despite a minor monthly dip, the firm is expanding capacity.

Health Canada's Priority Review for a new Duchenne muscular dystrophy drug signals hope for patients and a strategic test of Canada's rare disease market.

A UK firm's regulatory milestone is more than just compliance; it's a strategic masterclass in building the resilient systems needed to fight food allergies.

Questex's Fierce Biotech is launching a UK event, but this is more than expansion. It’s a calculated bet on London's future as a biotech superpower.

Logitech's new Mobi Fold isn't just a clever gadget. It's a strategic assault on the trackpad, aiming to close the productivity gap for hybrid professionals.

A strategic pivot from commercial real estate to the hard assets of the new economy reveals where the smart money is flowing—and it’s not just into buildings.

As new drugs outpace manufacturing capacity, a French giant bets on local production in China to build the supply chains of tomorrow's therapies.

A groundbreaking partnership between Servier and n-Lorem Foundation blends pharma R&D muscle with non-profit agility to develop ASO therapies for the rarest of diseases.

Beyond art and music, China's UN-backed event in Geneva reveals a calculated investment in global influence, aiming to reshape multilateralism itself.

A new deal to push advanced solar tech into emerging markets is more than a sales win; it's a strategic blueprint for navigating the future of global energy.

A landmark deal locks in energy for Ukraine and Finland until 2044, cementing a small Baltic terminal as a powerhouse of European strategic resilience.

Leading Edge Materials confirms a low-cost, high-purity graphite process at its Swedish mine, positioning Woxna to supply Europe's booming EV battery market.

A new campaign pairs a star athlete with a robotic mower, revealing a deeper strategy to win the multi-billion-dollar race for autonomous home care.

A new study by SciBase and Castle Biosciences is testing technology to predict atopic dermatitis flares, promising a shift from reactive care to patient control.

Japanese artist Takuma Tanaka's journey from law to canvas culminates in a Miami exhibition that channels Bruce Lee's wisdom to challenge modern overthinking.

A global health giant is now targeting the world's financial system, arguing that crippling debt is a deadlier crisis than any disease. Is their plan a revolution or a fantasy?

In just two years, AIKO Energy has captured a significant slice of Australia's solar market. We dissect the strategy combining breakthrough tech and local focus.

Metrica Partners' public battle with WUS Printed Circuit exposes a billion-dollar valuation gap, testing Taiwan's new corporate governance reforms.

Biotech firm Sensorion drops one gene therapy to fast-track another, aiming to cure GJB2-related hearing loss, the leading cause of genetic deafness.